Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Silver Sponsor Molecular Devices at Society for Laboratory Automation and Screening 2023 International Conference and Exhibition


News provided by

Molecular Devices

Feb 22, 2023, 08:00 ET

Share this article

Share toX

Share this article

Share toX


Showcasing new industry collaborations, automated technology, and workflow innovations that span 3D biology, cell line development, and drug screening

SAN JOSE, Calif., Feb. 22, 2023 /PRNewswire-PRWeb/ -- Molecular Devices, LLC., a leading provider of high-performance life science solutions, is demonstrating its latest automated, high-throughput technology at this year's Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition from February 25 – March 1, 2023, in San Diego, Calif.

"Molecular Devices continues to focus on meeting scientists' organoid development and screening needs by acquiring a contract development and manufacturer of large-scale patient-derived organoids, and expanding our product portfolio to include automated 3D bioprinter and single-cell dispenser solutions," said Susan Murphy, President of Molecular Devices. "We look forward to showcasing how our deep expertise, partnerships, and innovative technologies will open the future of next-generation drug discovery."

We look forward to showcasing how our deep expertise, partnerships, and innovative technologies will open the future of next-generation drug discovery.

Post this

Attendees can visit booth #917 to connect with subject matter experts on the company's latest announcements and advancements in cell line development, 3D biology, and drug screening.

3D biology business acquisition and collaborations
Until recently, organoids have been unsuitable for large-scale drug development due to the laborious nature of growing consistently uniform and robust 3D cell cultures. Through a strategic acquisition and industry collaborations, Molecular Devices is demystifying the process of creating high-volume, viable, and reproducible organoids for drug discovery.

The company recently acquired Cellesce, known for its reliable, assay-ready, patient-derived organoids at scale. When complemented by Molecular Devices' high-performance, automated hardware and software solutions, the offering is a first-of-its-kind, turnkey solution for organoid development, screening, and analysis.

New collaborations with organoid experts such as HUB Organoids (HUB) and HeartBeat.bio are supporting continued development of next-generation 3D biology technologies that drive step-change reduction in pre-clinical to clinical drug attrition. Molecular Devices is using intestinal organoids from HUB and cardiac organoids from HeartBeat.bio to demonstrate proof of concept for an end-to-end automated workflow that makes 3D biology accessible to the broader scientific community.

Featured automated technologies
Within automated workflows on display will be the recently launched BioAssemblyBot® 400 (BAB 400), as well as the DispenCell™ Single-Cell Dispenser.

Added to the company's instrument offerings in the last year include an enhanced BAB 400 from Advanced Solutions Life Sciences. Alongside Molecular Devices' ImageXpress® Cellular Imaging Systems and IN Carta® Image Analysis Software, the automated bioprinting platform aids life scientists in overcoming challenges with reproducing consistent, complex organoid models at scale for drug development.

Joining its line of biopharmaceutical solutions is the award-winning DispenCell™ Single-Cell Dispenser – an automated laboratory instrument designed for fast, easy, and gentle single-cell isolation – from SEED Biosciences Ltd. The technology enables scientists to isolate single-cell lines three times faster and at lower cost compared to existing solutions.

Short Courses, tutorials, podium presentations, and posters
Throughout the show, Molecular Devices and its collaborators will showcase how the company's life science solutions enable end-to-end automated workflows for advanced scientific discovery.

Level Up Your 3D Cell Culture: From Research to High Throughput on Sunday, February 26, 2023: A short course co-led by scientists from Corning Life Sciences and Molecular Devices.

Automating Organoid Models and Assay Workflows on Monday, February 27, 2023: A tutorial delivered by experts from Advanced Solutions Life Sciences and Molecular Devices.

A novel approach for label-free drug efficacy analyses of pancreatic cancer organoids using high-content imaging on Monday, February 27, 2023: A podium presentation delivered by SUN Bioscience featuring Molecular Devices technology.

Engineering next generation organoids for biomedical research and drug development on Monday, February 27, 2023: A podium presentation delivered by Center for Stem Cell and Organoid Medicine (CuSTOM) at Cincinnati Children's Hospital Medical Center (CCHMC) featuring Molecular Devices technology.

Leverage automated workflows to enable complex 3D organoid assays on Tuesday, February 28, 2023: Poster by Molecular Devices.

Novel analysis of neural outgrowth in 3D reconstructed human brain micro-tissues with application in compound screening on Tuesday, February 28, 2023: Poster by Molecular Devices.

Automation of Complex Organoid Culture and Assay Workflows on Tuesday, February 28, 2023: Poster by Advanced Solutions Life Sciences featuring Molecular Devices and Cellesce technologies.

A microwell platform to standardize human rectal organoid cultures for high-content imaging and phenotypic analyses on Tuesday, February 28, 2023: SUN Bioscience poster featuring Molecular Devices technology.

For an overview of where to find Molecular Devices at SLAS 2023, visit the company's webpage here.

About Molecular Devices, LLC.
Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California with offices around the globe.

# # #

Media Contact

Amy Smith, Molecular Devices, 1 4083344699, [email protected]

SOURCE Molecular Devices

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.